Kalender

Konferenzen und Finanzkalender

Der Finanzkalender dient nur als Anhaltspunkt, und die Gruppe kann die Veröffentlichungstermine ändern, wenn sie dies für notwendig erachtet.

Bevorstehende Ereignisse

February 16, 2023

2022 Revenue and Cash

March 23, 2023

2022 Annual Results

April 3, 2023 - April 6, 2023

World Vaccine Congress 2023

Ort: Washington D.C., U.S.

May 4, 2023

Q1 Financial Results

Vergangene Ereignisse

January 24, 2023

Invest Securities BioMed Forum

Ort: Paris

January 9, 2023 - January 12, 2023

J.P. Morgan 41st Annual Healthcare Conference 2023 San Francisco

Ort: San Francisco

January 5, 2023 - January 6, 2022

ODDO BHF Forum 2023

Ort: Lyon

7. Dezember 2022 - 9. Dezember 2022

Joint International Tropical Medicine Meeting (JITMM) 2022

Ort: Bangkok

6. Dezember 2022

Investorentag

Uhrzeit: 10 am - 12 pm U.S. Eeatern Time Ort: New York City

Live event und Webcast

• Um sich für die Veranstaltung anzumelden, klicken Sie bitte hier.

December 5, 2022 - December 7, 2022

Congreso Internacional de Infectología Pediátrica CEIP

Ort: Cali, Colombia

November 15, 2022 - November 17, 2022

Jefferies London Healthcare Conference

Ort: London

• Press Release: Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference

10. November 2022

9M 2022 Results

Uhrzeit: 3 pm CET Ort: Virtual event

Earnings Call

• Webcast Link
• Analyst presentation

6. November 2022 - 9. November 2022

Europäischer Kongress der International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Ort: Wien

Valneva will present two posters: "Burden of Illness and Paucity of Treatment of the Mosquito-Borne Chikungunya Virus (CHIKV)” and “The Economic Burden of the Globally Spreading Chikungunya Virus: A Systematic and Targeted Review.”

30. Oktober 2022 - 3. November 2022

American Society of Tropical Medicine and Hygiene (ASTMH)

Uhrzeit: November 1, 2022 at 10:15am PST Ort: Seattle

Valneva will present on the Phase 3 clinical development of its single-shot chikungunya vaccine candidate on November 1, 2022 at 10:15am PST during an in-person scientific session.